Alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine are being probed, a contract company involved in the research has confirmed.
Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson, who worked for the company during this time, told the British Medical Journal that the trial was riddled with issues, including the falsification of data.
